Shares of Gland Pharma rallied on Monday after the company reported a 97% YoY surge in Q4 profit and strong revenue growth, driven by its CDMO business. The board also announced a ₹20-per-share final dividend for FY26, boosting investor sentiment.
Shares of Gland Pharma rallied on Monday after the company reported a 97% YoY surge in Q4 profit and strong revenue growth, driven by its CDMO business. The board also announced a ₹20-per-share final dividend for FY26, boosting investor sentiment. by Soban News (international And National News)